TLR9 and systemic lupus erythematosus: Although patients vary in their clinical presentations, the unifying molecular hallmark of SLE is autoantibody production against DNA- and RNA-containing targets, driven by endosomal Toll-like receptors (TLRs) TLR7 and TLR9 (3).